Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors is a research paper published in Oncogene (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | National Institutes of Health
Grant: T32 CA9685-29
U.S. Department of Health & Human Services | National Institutes of Health
Grant: CA 249663-A1
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: T32 CA009685
National Institutes of Health
Grant: 5R01CA249663-05
Improving efficacy of radioiodine treatment of thyroid cancer
National Institutes of Health
Grant: 5T32CA009685-23
Head and Neck Training Program in Surgical Oncology
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Fields of Study
MeSH Terms
Keywords